Ionis Pharmaceuticals Inc. Common Stock vs Envista Holdings Corporation Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Envista Holdings Corporation Common Stock trades at $22.52 (market cap $3.64B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Envista Holdings Corporation Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Envista Holdings Corporation Common Stock for 0 Days on average.
| IONS | NVST | |
|---|---|---|
Market Cap | $7.04B | $3.64B |
Volume | 2,977,440 | 2,411,697 |
Sector | Health | Health |
52-Week High | $86.50 | $30.26 |
52-Week Low | $42.38 | $18.95 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $4.10B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Envista Holdings Corporation is a global dental products company that develops, manufactures, and markets dental implants, orthodontic systems, and other consumables and equipment for dental professionals worldwide.
Read more on NVST →